U.S. stock index futures rose on Thursday as investors looked ahead to the start of a central banking summit in Jackson Hole, Wyoming.US Marketsread more
"My sense was we've added accommodation and it wasn't required in my view," George tells CNBC's Steve Liesman.Investingread more
Apple plans to unveil three new iPhones in September, including two new "Pro" models and a successor to the iPhone XR, Bloomberg reported Thursday.Technologyread more
Corporate profits posted modest growth in the second quarter as companies brace for slowing global growth.Retailread more
Kraft has filed a contempt motion against the CFTC over a press release announcing the $16 million fine to settle claims of manipulating wheat prices.Food & Beverageread more
Former Prudent Bear Fund manager David Tice is urging investors to brace for a massive downturn.Trading Nationread more
A ruling against J&J could mean more big payouts in similar cases across the country.Health and Scienceread more
Democratic candidates face an August 28 deadline to qualify for the September debate.2020 Electionsread more
Sterling hit a three-week high against the dollar Thursday after German Chancellor Angela Merkel said a solution to the Irish "backstop" is possible before the October 31...Europe Economyread more
Target shares closed Wednesday up more than 20%, after the retailer reported impressive profit growth and a spike in traffic that surpassed analysts' expectations.Retailread more
"If I could borrow without paying any interest, or ever pay the money back, I would borrow as much as I could, too," the 'Trumponomics' co-author says.Economyread more
March 22 (Reuters) - Allergan Plc plans to elect an independent board chairman, starting with the next leadership transition, the Botox maker said on Friday, as the drugmaker responds to calls from hedge fund Appaloosa LP to separate the roles of chairman and chief executive officer.
Appaloosa, led by billionaire David Tepper, has been pressing Allergan since last year to separate the roles, but the company has said it would do so only when the person who now holds the positions is replaced.
Brent Saunders currently holds the roles, and Allergan has said implementing Appaloosa's recommendations would be "highly disruptive" to the company's operations and impact his ability to continue to execute its current strategy.
Allergan also said https://www.sec.gov/Archives/edgar/data/1578845/000119312519083731/d633114d8k.ht m in a regulatory filing on Friday that it had formed a committee to oversee mergers, acquisitions, divestitures and other transactions.
The company also named Thomas Freyman as the chair of the compensation committee, replacing Catherine Klema, who will not be standing for re-election.
A spokesman for Tepper did not immediately respond to a request for comment.
The company in February had named former CEO of drugmaker Celgene, Robert Hugin, as a director, saying the appointment reflected its commitment to "active board refreshment".
(Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shailesh Kuber and Sriraj Kalluvila)